u/ines_castellanos
Contributes reviews on supplier material. Based in Zadar.
member · joined 17 Aug 2025
Comments — page 3 of 3
comment on [PSA] VendorInvestigate results are area% by default and people keep forgetting in c/semaglutide · 69 points · 2 years ago
titration speed is titration plus side effects, period
Adding to this: weekly dosing is doing more work than the comment implies.
comment on genuine question about TRIUMPH that I am slightly embarrassed to ask in c/trialwatch · 16 points · 2 years ago
event rates are more informative than hazard ratios alone
Counter-anecdote: opposite result, same dose. Which mostly tells us the variance is huge.
comment on week 36 check-in — 27kg down, sulphur burps manageable, one thing confusing me in c/semaglutide · 51 points · 2 years ago
Disagree. What you are describing is consistent with Wegovy, not with what you concluded.
comment on [Results] 77 weeks, 21kg, and endpoint was the hard part in c/trialwatch · 32 points · 2 years ago
off-label use data is different from approved-indication data
comment on [Meta] proposal — a flair for tier 3 posts in c/glp1uk · 114 points · 2 years ago
the two-year waiting list is accurate for most of England
comment on week 16 check-in — 46kg down, early fullness manageable, one thing confusing me in c/trialwatch · 51 points · 2 years ago
dropout handling matters, especially on GI-heavy populations
comment on [Results] 72 weeks, 31kg, and Wegovy was the hard part in c/semaglutide · 114 points · 2 years ago
Small correction: the trial was 11 weeks, not 16. Does not change your point but people will quote it.
comment on TRIUMPH — 13 things I got wrong before I got it right in c/trialwatch · 69 points · 2 years ago
absolute risk reduction, not relative risk reduction, that is how you decide
comment on small win: Ozempic stopped being a problem at week 20 in c/semaglutide · 303 points · 2 years ago
the injection-site soreness passes. i promise. not medical advice.